These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33707951)

  • 1.
    Li CH; Huang R; Makabenta JM; Schmidt-Malan S; Patel R; Rotello VM
    Microbiol Insights; 2021; 14():1178636121997121. PubMed ID: 33707951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer-Based Bioorthogonal Nanocatalysts for the Treatment of Bacterial Biofilms.
    Huang R; Li CH; Cao-Milán R; He LD; Makabenta JM; Zhang X; Yu E; Rotello VM
    J Am Chem Soc; 2020 Jun; 142(24):10723-10729. PubMed ID: 32464057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in controllable bioorthogonal catalysis for prodrug activation.
    Liu X; Huang T; Chen Z; Yang H
    Chem Commun (Camb); 2023 Oct; 59(84):12548-12559. PubMed ID: 37791560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inorganic nanoparticles as scaffolds for bioorthogonal catalysts.
    Hirschbiegel CM; Zhang X; Huang R; Cicek YA; Fedeli S; Rotello VM
    Adv Drug Deliv Rev; 2023 Apr; 195():114730. PubMed ID: 36791809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On-Demand Activatable and Integrated Bioorthogonal Nanocatalyst against Biofilm-Associated Infections.
    Sun Y; Zhao H; Pu F; Liu H; Chen L; Ren J; Qu X
    Adv Healthc Mater; 2024 Sep; 13(23):e2400899. PubMed ID: 38752875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular Activation of Anticancer Therapeutics Using Polymeric Bioorthogonal Nanocatalysts.
    Zhang X; Landis RF; Keshri P; Cao-Milán R; Luther DC; Gopalakrishnan S; Liu Y; Huang R; Li G; Malassiné M; Uddin I; Rondon B; Rotello VM
    Adv Healthc Mater; 2021 Mar; 10(5):e2001627. PubMed ID: 33314745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradable ZnS-Supported Bioorthogonal Nanozymes with Enhanced Catalytic Activity for Intracellular Activation of Therapeutics.
    Zhang X; Lin S; Huang R; Gupta A; Fedeli S; Cao-Milán R; Luther DC; Liu Y; Jiang M; Li G; Rondon B; Wei H; Rotello VM
    J Am Chem Soc; 2022 Jul; 144(28):12893-12900. PubMed ID: 35786910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ activation of therapeutics through bioorthogonal catalysis.
    Wang W; Zhang X; Huang R; Hirschbiegel CM; Wang H; Ding Y; Rotello VM
    Adv Drug Deliv Rev; 2021 Sep; 176():113893. PubMed ID: 34333074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Dual-Mechanism Targeted Bioorthogonal Prodrug Therapy.
    Yao Q; Lin F; Lu C; Zhang R; Xu H; Hu X; Wu Z; Gao Y; Chen PR
    Bioconjug Chem; 2023 Dec; 34(12):2255-2262. PubMed ID: 37955377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioorthogonal strategies for the in vivo synthesis or release of drugs.
    Lozhkin B; Ward TR
    Bioorg Med Chem; 2021 Sep; 45():116310. PubMed ID: 34365101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-natural gelatin-based bioorthogonal catalysts for efficient eradication of bacterial biofilms.
    Nabawy A; Huang R; Luther DC; Zhang X; Li CH; Makabenta JM; Rotello VM
    Chem Sci; 2022 Oct; 13(41):12071-12077. PubMed ID: 36349111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modular Nanoparticulate Prodrug Design Enables Efficient Treatment of Solid Tumors Using Bioorthogonal Activation.
    Miller MA; Mikula H; Luthria G; Li R; Kronister S; Prytyskach M; Kohler RH; Mitchison T; Weissleder R
    ACS Nano; 2018 Dec; 12(12):12814-12826. PubMed ID: 30550257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioorthogonal catalytic patch.
    Chen Z; Li H; Bian Y; Wang Z; Chen G; Zhang X; Miao Y; Wen D; Wang J; Wan G; Zeng Y; Abdou P; Fang J; Li S; Sun CJ; Gu Z
    Nat Nanotechnol; 2021 Aug; 16(8):933-941. PubMed ID: 33972760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte-mediated delivery of bioorthogonal nanozymes for selective targeting of bacterial infections.
    Gupta A; Das R; Makabenta JM; Gupta A; Zhang X; Jeon T; Huang R; Liu Y; Gopalakrishnan S; Milán RC; Rotello VM
    Mater Horiz; 2021 Nov; 8(12):3424-3431. PubMed ID: 34700339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotransporting Self-Assembled Nanofactories Using Polymer Vesicles with Molecular Permeability for Enzyme Prodrug Cancer Therapy.
    Nishimura T; Sasaki Y; Akiyoshi K
    Adv Mater; 2017 Sep; 29(36):. PubMed ID: 28714209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioorthogonal nanozymes for breast cancer imaging and therapy.
    Zhang X; Liu Y; Doungchawee J; Castellanos-García LJ; Sikora KN; Jeon T; Goswami R; Fedeli S; Gupta A; Huang R; Hirschbiegel CM; Cao-Milán R; Majhi PKD; Cicek YA; Liu L; Jerry DJ; Vachet RW; Rotello VM
    J Control Release; 2023 May; 357():31-39. PubMed ID: 36948419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Efficiency of Pd(0)-Based Single Chain Polymeric Nanoparticles for
    Deng L; Sathyan A; Adam C; Unciti-Broceta A; Sebastian V; Palmans ARA
    Nano Lett; 2024 Feb; 24(7):2242-2249. PubMed ID: 38346395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DNA-Gated and Self-Protected Bioorthogonal Catalyst for Nanozyme-Assisted Safe Cancer Therapy.
    Zhang Y; Zhang L; Wang W; Deng Q; Liu M; Zhu Z; Liu H; Ren J; Qu X
    Angew Chem Int Ed Engl; 2023 Aug; 62(32):e202306395. PubMed ID: 37268594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A General Strategy for Macrotheranostic Prodrug Activation: Synergy between the Acidic Tumor Microenvironment and Bioorthogonal Chemistry.
    Dong Y; Tu Y; Wang K; Xu C; Yuan Y; Wang J
    Angew Chem Int Ed Engl; 2020 Apr; 59(18):7168-7172. PubMed ID: 32003112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "One-stitch" bioorthogonal prodrug activation based on cross-linked lipoic acid nanocapsules.
    Wang L; Jing P; Tan J; Liao C; Chen Y; Yu Y; Zhang S
    Biomaterials; 2021 Jun; 273():120823. PubMed ID: 33930738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.